A Retrospective Chart Review of Screening on the Prevalence of Metabolic Syndrome (MetS) in an Irish Community Mental Health Service

References

• Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., … Smith, S. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120(16), 1640–1645.
   PubMed Web of Science ®Google Scholar
• Alberti, K. G., & Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation on diabetic medicine. Diabetic Medicine, 15(7), 539–553.
   PubMed Web of Science ®Google Scholar
• Alberti, K. G., Zimmet, P., & Shaw, J. E. (2006). Metabolic syndrome–A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Medicine, 23(5), 469–480.
   PubMed Web of Science ®Google Scholar
• Allison, D. B., Newcomer, J. W., Dunn, A. L., Blumenthal, J. A., Fabricatore, A. N., Daumit, G. L., … Alpert, J. E. (2009). Obesity among those with mental disorders: A National Institute of Mental Health meeting report. American Journal of Preventive Medicine, 36(4), 341–350.
   PubMed Web of Science ®Google Scholar
• Alosaimi, F. D., Abalhassan, M., Alhaddad, B., Alzain, N., Fallata, E., Alhabbad, A., … Alassiry, M. Z. (2017). Prevalence of metabolic syndrome and its components among patients with various psychiatric diagnoses and treatments: A cross-sectional study. General Hospital Psychiatry, 45, 62–69.
   PubMed Web of Science ®Google Scholar
• Barnes, T. R. E., Bhatti, S. F., Adroer, R., & Paton, C. (2015). Screening for the metabolic side effects of antipsychotic medication: Findings of a 6-year quality improvement programme in the UK. BMJ Open, 5(10), e007633.
   PubMed Web of Science ®Google Scholar
• Black, D. R., & Held, M. L. (2017). Cardiovascular risk screening for individuals with serious mental illness. Social Work in Health Care, 56(9), 809–821.
   PubMed Web of Science ®Google Scholar
• Boylan, E. A., McNulty, B. A., Walton, J., Flynn, A., Nugent, A. P., & Gibney, M. J. (2014). The prevalence and trends in overweight and obesity in Irish adults between 1990 and 2011. Public Health Nutrition, 17(11), 2389–2397.
   PubMed Web of Science ®Google Scholar
• Bressington, D., Mui, J., Mei, L. T., Gray, R., Cheung, E. F. C., & Wai, T. C. (2016). Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: A cross-sectional study. BMC Psychiatry, 16, 1–14.
   PubMed Web of Science ®Google Scholar
• Carrà, G., Bartoli, F., Carretta, D., Crocamo, C., Bozzetti, A., Clerici, M., … Bebbington, P. E. (2014). The prevalence of metabolic syndrome in people with severe mental illness: A mediation analysis. Social Psychiatry and Psychiatric Epidemiology, 49(11), 1739–1746.
   PubMed Web of Science ®Google Scholar
• Champion, J. D., Pierce, S., & Collins, J. L. (2015). Retrospective chart review of obesity and episodic and chronic illness among rural Mexican-American adolescents accessing rural health clinic services. International Journal of Nursing Practice, 21(3), 328–336.
   PubMed Web of Science ®Google Scholar
• Citrome, L., & Vreeland, B. (2008). Schizophrenia, obesity, and antipsychotic medications: What can we do? Postgraduate Medicine, 120(2), 18–33.
   PubMed Web of Science ®Google Scholar
• Correll, C. U., Druss, B. G., Lombardo, I., O’Gorman, C., Harnett, J. P., Sanders, K. N., … Cuffel, B. J. (2010). Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatients. Psychiatric Services, 61(9), 892–898.
   PubMedGoogle Scholar
• Correll, C. U., Ng-Mak, D., Stafkey-Mailey, D., Farrelly, E., Rajagopalan, K., & Loebel, A. (2017). Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: A real-world analysis. Annals of General Psychiatry, 9(16).
   Google Scholar
• Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., … Stubbs, B. (2017). Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: A large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry Official Journal of the World Psychiatric Association (WPA), 16(2), 163–180.
   PubMed Web of Science ®Google Scholar
• Curtis, J., Henry, C., Watkins, A., Newall, H., Samaras, K., & Ward, P. B. (2011). Metabolic abnormalities in an early psychosis service: A retrospective, naturalistic cross-sectional study. Early Intervention in Psychiatry, 5(2), 108–114.
   PubMed Web of Science ®Google Scholar
• Daumit, G. L., Goff, D. C., Meyer, J. M., Davis, V. G., Nasrallah, H. A., McEvoy, J. P., … Lieberman, J. A. (2008). Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophrenia Research, 105(1–3), 175–187.
   PubMed Web of Science ®Google Scholar
• De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H. (2009). Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry, 24(6), 412–424.
   PubMed Web of Science ®Google Scholar
• De Hert, M., Schreurs, V., Sweers, K., Van Eyck, D., Hanssens, L., Šinko, S., … McNeil, M. (2016). Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review. Baltimore, MD: Elsevier Science; Lippincott, Williams & Wilkins.
   Google Scholar
• Di Cesare, M., Bentham, J., Stevens, G. A., Zhou, B., Danaei, G., Lu, Y., … Miranda, J. J. (2016). Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet North American Edition, 387 (10026), 1377–1396.
   PubMed Web of Science ®Google Scholar
• Feeney, L., Kelly, F., Lee, J., Kelly, E., McLaughlin, S., & O’Boyle, J. H. (2007). Point prevalence of diabetes, obesity, hyperlipidemia, hypertension and smoking in outpatients on clozapine. Irish Journal of Psychological Medicine, 24(02), 59–61.
   PubMedGoogle Scholar
• Foguet Boreu, Q., Roura Poch, P., Bullón Chia, A., Mauri Martin, C., Gordo Serra, N., & Cecília Costa, R. (2013). Cardiovascular risk factors, cardiovascular risk and quality of life in patients with a severe mental disorder. Atencion Primaria, 45(3), 141–148.
   PubMed Web of Science ®Google Scholar
• Gardner-Sood, P., Lally, J., Smith, S., Atakan, Z., Ismail, K., Greenwood, K. E., … Gaughran, F. (2015). Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: Baseline data from the IMPaCT randomized controlled trial. Psychological Medicine, 45(12), 2619–2629.
   PubMed Web of Science ®Google Scholar
• Glasper, A. (2016). Caring for adults with severe mental illness and physical health problems. British Journal of Nursing, 25(22), 1266–1267.
   PubMedGoogle Scholar
• Gossage-Worrall, R., Holt, R. I. G., Barnard, K., Carey, M. E., Davies, M. J., Dickens, C., … Siddiqi, N. (2016). STEPWISE - STructured lifestyle education for people with SchizophrEnia: A study protocol for a randomised controlled trial. Trials, 17, 1–12.
   PubMed Web of Science ®Google Scholar
• Greenwood, P. J., & Shiers, D. E. (2016). Don’t just screen intervene; a quality improvement initiative to improve physical health screening of young people experiencing severe mental illness. Mental Health Review Journal, 21(1), 48–60.
   Web of Science ®Google Scholar
• Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., … Costa, F. (2005). Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Executive summary. Cardiology in Review, 13(6), 322–327.
   PubMedGoogle Scholar
• Gubbins, A., Lally, J., & McDonald, C. (2012). Metabolic syndrome in patients attending psychiatric day centres: Prevalence and associations. The Psychiatrist, 36(9), 326–331.
   Google Scholar
• Haw, C., & Rowell, A. (2011). Obesity and its complications: A survey of inpatients at a secure psychiatric hospital. The British Journal of Forensic Practice, 13(4), 270–277.
   Google Scholar
• John, A. P., Koloth, R., Dragovic, M., & Lim, S. C. B. (2009). Prevalence of metabolic syndrome among Australians with severe mental illness. Medical Journal of Australia, 190, 176–179.
   PubMed Web of Science ®Google Scholar
• Jonikas, J., Cook, J., Razzano, L., Steigman, P., Hamilton, M., Swarbrick, M., … Santos, A. (2016). Associations between gender and obesity among adults with mental illnesses in a community health screening study. Community Mental Health Journal, 52(4), 406–415.
   PubMed Web of Science ®Google Scholar
• Kamkar, M. Z., Sanagoo, A., Zargarani, F., Jouybari, L., & Marjani, A. (2016). Metabolic syndrome in patients with severe mental illness in Gorgan. Journal of Natural Science Biology & Medicine, 7(1), 62–67.
   PubMedGoogle Scholar
• Kelbrick, M., & Haw, C. (2008). An audit of physical examinations in a psychiatric intensive care unit. Journal of Psychiatric Intensive Care, 4(1–2), 35–42.
   Google Scholar
• Kioko, E., Williams, K., & Newhouse, B. (2016). Improving metabolic syndrome screening on patients on second generation antipsychotic medication. Archives of Psychiatric Nursing, 30, 671–677. Retrieved from http://dx.doi.org.dcu.idm.oclc.org/10.1016/j.apnu.2016.03.004.
   PubMed Web of Science ®Google Scholar
• Krane-Gartiser, K., Breum, L., Glümer, C., Linneberg, A., Madsen, M., Køster, A., … Fink-Jensen, A. (2011). Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics. Nordic Journal of Psychiatry, 65(5), 345–352.
   PubMed Web of Science ®Google Scholar
• Manu, P., Dima, L., Shulman, M., Vancampfort, D., De Hert, M., & Correll, C. U. (2015). Weight gain and obesity in schizophrenia: Epidemiology, pathobiology, and management. Acta Psychiatrica Scandinavica, 132(2), 97–108.
   PubMed Web of Science ®Google Scholar
• Martin, A., Neale, E. P., Batterham, M., & Tapsell, L. C. (2016). Identifying metabolic syndrome in a clinical cohort: Implications for prevention of chronic disease. Preventive Medicine Reports, 4, 502–506.
   PubMedGoogle Scholar
• Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012). Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: Systematic review and meta-analysis of screening practices. Psychological Medicine, 42(1), 125–147.
   PubMed Web of Science ®Google Scholar
• Mitchell, A. J., Vancampfort, D., De Herdt, A., Yu, W., & De Hert, M. (2013). Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophrenia Bulletin, 39(2), 295–305.
   PubMed Web of Science ®Google Scholar
• Nash, M. (2014). Physical health and well-being in mental health nursing: Clinical skills for practice (2nd ed.). Berkshire, UK: Open University Press.
   Google Scholar
• O’Neill, S., & O’Driscoll, L. (2015). Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obesity Reviews, 16(1), 1–12.
   PubMed Web of Science ®Google Scholar
• Paton, C., Esop, R., Young, C., & Taylor, D. (2004). Obesity, dyslipidemia and smoking in an in patient population treated with antipsychotic drugs. Acta Psychiatrica Scandinavica, 110(4), 299–305.
   PubMed Web of Science ®Google Scholar
• Qin, L., Knol, M. J., Corpeleijn, E., & Stolk, R. P. (2010). Does physical activity modify the risk of obesity for type 2 diabetes: A review of epidemiological data. European Journal of Epidemiology, 25(1), 5–12.
   PubMed Web of Science ®Google Scholar
• Rawat, V. S., Ganesh, S., Bijjal, S., Shanivaram Reddy, K., Agarwal, V., Devi, R., … Thirthalli, J. (2018). Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population. Schizophrenia Research, 192, 102–107.
   PubMed Web of Science ®Google Scholar
• Rollins, A. L., Wright-Berryman, J., Henry, N. H., Quash, A. M., Benbow, K., Bonfils, K. A., … Salyers, M. P. (2017). Managing physical and mental health conditions: Consumer perspectives on integrated care. Social Work in Mental Health, 15(1), 66–79.
   PubMed Web of Science ®Google Scholar
• Rosenbaum, S., Nijjar, S., Watkins, A., Garwood, N., Sherrington, C., & Tiedemann, A. (2014). Nurse-assessed metabolic monitoring: A file audit of risk factor prevalence and impact of an intervention to enhance measurement of waist circumference. International Journal of Mental Health Nursing, 23(3), 252–256.
   PubMed Web of Science ®Google Scholar
• Šagud, M., Mihaljević-Peleš, A., Mück-Šeler, D., Pivac, N., Vuksan-Ćusa, B., Brataljenović, T., … Jakovljević, M. (2009). Smoking and schizophrenia. Psychiatria Danubina, 21(3), 371–375.
   PubMed Web of Science ®Google Scholar
• Saloojee, S., Burns, J. K., & Motala, A. A. (2016). Metabolic syndrome in South African patients with severe mental illness: Prevalence and associated risk factors. PLoS One, 11(2), 1–14.
   Web of Science ®Google Scholar
• Scuteri, A., Laurent, S., Cucca, F., Cockcroft, J., Cunha, P. G., Mañas, L. R., … Nilsson, P. M. (2015). Metabolic syndrome across Europe: Different clusters of risk factors. European Journal of Preventive Cardiology, 22(4), 486–491. doi: 10.1177/2047487314525529
   Google Scholar
• Sicras-Mainar, A., Maurino, J., Ruiz-Beato, E., & Navarro-Artieda, R. (2014). Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia. Neuropsychiatric Disease and Treatment, 11, 51–57.
   PubMed Web of Science ®Google Scholar
• Simonelli-Muñoz, A. J., Fortea, M. I., Salorio, P., Gallego-Gomez, J. I., Sánchez-Bautista, S., & Balanza, S. (2012). Dietary habits of patients with schizophrenia: A self-reported questionnaire survey. International Journal of Mental Health Nursing, 21(3), 220–228.
   PubMed Web of Science ®Google Scholar
• Stanley, S. H., & Laugharne, J. D. E. (2012). Obesity, cardiovascular disease and type 2 diabetes in people with a mental illness: A need for primary health care. Australian Journal of Primary Health, 18(3), 258–264.
   PubMed Web of Science ®Google Scholar
• Stanton, R., Platania-Phung, C., Gaskin, C. J., & Happell, B. (2016). Screening for metabolic syndrome in mental health consumers using an electronic metabolic monitoring form. Issues in Mental Health Nursing, 37(4), 239–244.
   PubMed Web of Science ®Google Scholar
• Sung, K. C., Ryu, S., Lee, J. Y., Lee, S., Cheong, E., Kim, J. Y., … Byrne, C. D. (2016). All cause mortality and body mass index in a young Asian occupational cohort without baseline metabolic syndrome components. International Journal of Cardiology, 224, 271–278.
   PubMed Web of Science ®Google Scholar
• Tirupati, S., & Chua, L. E. (2007). Obesity and metabolic syndrome in a psychiatric rehabilitation service. Australian & New Zealand Journal of Psychiatry, 41(7), 606–610.
   PubMed Web of Science ®Google Scholar
• Unwin, N., Gan, D., & Whiting, D. (2010). The IDF diabetes atlas: Providing evidence, raising awareness and promoting action. Diabetes Research & Clinical Practice, 87(1), 2–3.
   PubMed Web of Science ®Google Scholar
• Vancampfort, D., Hallgren, M., Mugisha, J., De Hert, M., Probst, M., Monsieur, D., & Stubbs, B. (2016). The prevalence of metabolic syndrome in alcohol use disorders: A systematic review and meta-analysis. Alcohol & Alcoholism, 51(5), 515–521.
   PubMed Web of Science ®Google Scholar
• Vassar, M., & Holzmann, M. (2013). The retrospective chart review: Important methodological considerations. Journal of Educational Evaluation for Health Professions, 10, 12. 10.3352/jeehp.2013.10.12
   PubMedGoogle Scholar
• Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011). IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research & Clinical Practice, 94(3), 311–321.
   PubMed Web of Science ®Google Scholar